IP Verse

Stada Arzneimittel Ag opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Stada Arzneimittel Ag

Patent Number:
EP3263106
Title:
Method For Suppressing Bitterness Of Quinoline Derivative
Applicant:
EISAI R&D MANAGEMENT CO., LTD.
Opposition Date:
Jul 25, 2024
Patent Number:
EP3996688
Title:
Pharmaceutical Preparation
Applicant:
MERCK PATENT GMBH
Opposition Date:
Jun 6, 2024
Patent Number:
EP3618875
Title:
Combination Therapy
Applicant:
NOVARTIS AG
Opposition Date:
Jan 4, 2024
Patent Number:
EP3067043
Title:
Pharmaceutical Compositions Based On Superstructures Of Angiotensin Receptor Antagonist/Blocker (Arb) And Neutral Endopeptidase (Nep) Inhibitor
Applicant:
NOVARTIS AG
Opposition Date:
Aug 29, 2023
Patent Number:
EP3283058
Title:
Ribociclib Tablet
Applicant:
NOVARTIS AG
Opposition Date:
Aug 16, 2023
Patent Number:
EP2981255
Title:
Therapeutic Uses Of Empagliflozin
Applicant:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Opposition Date:
Jun 13, 2023
Patent Number:
EP3524595
Title:
High-Purity Quinoline Derivative And Method For Manufacturing Same
Applicant:
EISAI R&D MANAGEMENT CO., LTD.
Opposition Date:
May 10, 2023
Patent Number:
EP3560498
Title:
Combination Comprising An Mek Inhibitor And A B-Raf Inhibitor
Applicant:
NOVARTIS AG
Opposition Date:
May 9, 2023
Patent Number:
EP3448416
Title:
Semaglutide In Cardiovascular Conditions
Applicant:
NOVO NORDISK A/S
Opposition Date:
May 5, 2023
Patent Number:
EP3206693
Title:
Prostaglandin Conjugates And Derivatives For Treating Glaucoma And Ocular Hypertension
Applicant:
ALCON INC.
Opposition Date:
Apr 27, 2023

Latest patents of Stada Arzneimittel Ag opposed by its competitors

Patent:
EP3324936
Grant Date:
Sep 28, 2022
Title:
Method For Producing A Bortezomib Ester Solution
Oppositions:
6
Patent:
EP3324937
Grant Date:
Aug 17, 2022
Title:
Ready-To-Use Bortezomib Solution
Oppositions:
7
Patent:
EP1591105
Grant Date:
May 27, 2020
Title:
Use Of Antioxidants For The Preparation Of Pharmaceutical Or Cosmetic Compositions For Protecting The Skin From Damages By Infrared-Radiations
Oppositions:
6
Patent:
EP2233127
Grant Date:
May 27, 2020
Title:
Use Of Antioxidants For The Preparation Of Pharmaceutical Or Cosmetic Compositions For Protecting The Skin From Damages By Infrared-Radiations
Oppositions:
9

Competitors of Stada Arzneimittel Ag

NOVARTIS AG

BEIERSDORF AG

PFIZER INC.

Want to track Stada Arzneimittel Ag?

Feel free to send us a message here and we will get back to you